BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24646915)

  • 1. Over-expression of platelet-derived growth factor-D promotes tumor growth and invasion in endometrial cancer.
    Wang Y; Qiu H; Hu W; Li S; Yu J
    Int J Mol Sci; 2014 Mar; 15(3):4780-94. PubMed ID: 24646915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor-D promotes ovarian cancer invasion by regulating matrix metalloproteinases 2 and 9.
    Wang Y; Hu C; Dong R; Huang X; Qiu H
    Asian Pac J Cancer Prev; 2011; 12(12):3367-70. PubMed ID: 22471482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TESTIN suppresses tumor growth and invasion via manipulating cell cycle progression in endometrial carcinoma.
    Gu Z; Ding G; Liang K; Zhang H; Guo G; Zhang L; Cui J
    Med Sci Monit; 2014 Jun; 20():980-7. PubMed ID: 24929083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H; Sun JD; Yan LJ; Zhao XP
    Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
    Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
    Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
    Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
    Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells.
    Devarajan E; Song YH; Krishnappa S; Alt E
    Int J Cancer; 2012 Sep; 131(5):1023-31. PubMed ID: 22038895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells.
    Kong D; Wang Z; Sarkar SH; Li Y; Banerjee S; Saliganan A; Kim HR; Cher ML; Sarkar FH
    Stem Cells; 2008 Jun; 26(6):1425-35. PubMed ID: 18403754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6.
    Wang X; Chen T
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell protein Piwil1 endowed endometrial cancer cells with stem-like properties via inducing epithelial-mesenchymal transition.
    Chen Z; Che Q; He X; Wang F; Wang H; Zhu M; Sun J; Wan X
    BMC Cancer; 2015 Oct; 15():811. PubMed ID: 26506848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference influenced the proliferation and invasion of XWLC-05 lung cancer cells through inhibiting aquaporin 3.
    Xiong G; Chen X; Zhang Q; Fang Y; Chen W; Li C; Zhang J
    Biochem Biophys Res Commun; 2017 Apr; 485(3):627-634. PubMed ID: 28189680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-183 induces epithelial-mesenchymal transition and promotes endometrial cancer cell migration and invasion in by targeting CPEB1.
    Xiong H; Chen R; Liu S; Lin Q; Chen H; Jiang Q
    J Cell Biochem; 2018 Nov; 119(10):8123-8137. PubMed ID: 29923214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Glucose Promotes Epithelial-Mesenchymal Transition of Uterus Endometrial Cancer Cells by Increasing ER/GLUT4-Mediated VEGF Secretion.
    Gu CJ; Xie F; Zhang B; Yang HL; Cheng J; He YY; Zhu XY; Li DJ; Li MQ
    Cell Physiol Biochem; 2018; 50(2):706-720. PubMed ID: 30308493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin.
    Yan H; Sun BM; Zhang YY; Li YJ; Huang CX; Feng FZ; Li C
    Int J Mol Med; 2018 Nov; 42(5):2469-2480. PubMed ID: 30226564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of platelet-derived growth factor-D as a poor prognosticator in endometrial cancer.
    Ding J; Li XM; Liu SL; Zhang Y; Li T
    Asian Pac J Cancer Prev; 2014; 15(8):3741-5. PubMed ID: 24870786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of platelet-derived growth factor-D expression blockades NF-κB pathway to inhibit cell proliferation and invasion as well as induce apoptosis in esophageal squamous cell carcinoma.
    Han Y; Guo XH; Zheng QF; Zhu YL; Fan YY; Zhang XY
    Mol Biol Rep; 2013 Mar; 40(3):2473-83. PubMed ID: 23187740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.
    Xu L; Tong R; Cochran DM; Jain RK
    Cancer Res; 2005 Jul; 65(13):5711-9. PubMed ID: 15994946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
    Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
    Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells.
    Lu JF; Hu ZQ; Yang MX; Liu WY; Pan GF; Ding JB; Liu JZ; Tang L; Hu B; Li HC
    Clin Breast Cancer; 2022 Feb; 22(2):e173-e183. PubMed ID: 34272173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.